These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 27659181)
1. The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer. Leal AS; Sporn MB; Pioli PA; Liby KT Carcinogenesis; 2016 Dec; 37(12):1170-1179. PubMed ID: 27659181 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice. Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025 [TBL] [Abstract][Full Text] [Related]
3. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer. Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595 [TBL] [Abstract][Full Text] [Related]
4. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice. Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma. Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839 [TBL] [Abstract][Full Text] [Related]
6. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699 [TBL] [Abstract][Full Text] [Related]
7. Development of thymic tumor in [LSL:Kras Liot S; El Kholti N; Balas J; Genestier L; Verrier B; Valcourt U; Lambert E Sci Rep; 2021 Jul; 11(1):15075. PubMed ID: 34302028 [TBL] [Abstract][Full Text] [Related]
8. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346 [TBL] [Abstract][Full Text] [Related]
9. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice. Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833 [TBL] [Abstract][Full Text] [Related]
11. Proteasome activity is required for the initiation of precancerous pancreatic lesions. Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456 [TBL] [Abstract][Full Text] [Related]
12. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959 [TBL] [Abstract][Full Text] [Related]
13. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice. Kaur K; Chang HH; Topchyan P; Cook JM; Barkhordarian A; Eibl G; Jewett A Front Immunol; 2018; 9():1229. PubMed ID: 29977235 [TBL] [Abstract][Full Text] [Related]
14. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057 [TBL] [Abstract][Full Text] [Related]
15. The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice. Hoffman MT; Kemp SB; Salas-Escabillas DJ; Zhang Y; Steele NG; The S; Long D; Benitz S; Yan W; Margolskee RF; Bednar F; Pasca di Magliano M; Wen HJ; Crawford HC Cell Mol Gastroenterol Hepatol; 2021; 11(2):349-369. PubMed ID: 32882403 [TBL] [Abstract][Full Text] [Related]
17. The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge. Auletta JJ; Alabran JL; Kim BG; Meyer CJ; Letterio JJ J Interferon Cytokine Res; 2010 Jul; 30(7):497-508. PubMed ID: 20626291 [TBL] [Abstract][Full Text] [Related]
18. Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer. Leal AS; Liby KT Curr Protoc Pharmacol; 2018 Dec; 83(1):e48. PubMed ID: 30325112 [TBL] [Abstract][Full Text] [Related]
19. Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway. Ahmed H; Amin U; Sun X; Pitts DR; Li Y; Zhu H; Jia Z Exp Biol Med (Maywood); 2022 Apr; 247(8):683-690. PubMed ID: 35034476 [TBL] [Abstract][Full Text] [Related]